Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review

INTRODUCTION: Belimumab is a recombinant human monoclonal antibody that binds to soluble B-lymphocyte stimulator and inhibits its biological activity. Since receiving approvals for the treatment of systemic lupus erythematosus (SLE), several observational studies have investigated the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shirley P., Snedecor, Sonya J., Nanji, Sakina, Lloyd, Emily, Bell, Christopher F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314515/
https://www.ncbi.nlm.nih.gov/pubmed/35596922
http://dx.doi.org/10.1007/s40744-022-00454-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314515/
https://www.ncbi.nlm.nih.gov/pubmed/35596922
http://dx.doi.org/10.1007/s40744-022-00454-9

Ejemplares similares